Application of Aerobic and Resistance Exercise in Blood Glucose Control in Pregnant Women With GDM

February 4, 2024 updated by: Second Affiliated Hospital of Wenzhou Medical University

Application of Aerobic and Resistance Exercise in Blood Glucose Control in Pregnant Women With GDM.

Objective:The aim of this study was to explore the rationality and clinical value of aerobic exercise during pregnancy in blood glucose control of pregnant women with GDM, and to provide theoretical basis for more appropriate clinical exercise management.

Method:The subjects of gestational diabetes in the hospital from March 2023 to May 2024 were studied. The exercise exercise with daily responsible nurses was based on resistance exercise, mainly with upper limb muscle exercise, supplemented by lower limb muscle exercise and aerobic exercise. Fasting blood glucose, 2 hours postprandial blood glucose and HbA1c in pregnant women with GDM were monitored.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Xiaofen Zhang
  • Phone Number: +8613968824305
  • Email: 7850758@qq.com

Study Locations

  • China
    • Zhejiang
      • Wenzhou, Zhejiang, China, 325027
        • Recruiting
        • department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Pregnant women with GDM without contraindications.
  • Pregnant women with GDM who volunteered to participate in the project.
  • Pregnant women give informed consent.

Exclusion Criteria:

  • Pregnant women give up voluntarily.
  • Hypoglycemia: In the presence of dizziness and other uncomfortable symptoms, people should stop exercising immediately, monitor blood sugar, and always prepare candy.
  • Abdominal pain, vaginal bleeding and other symptoms of contraction should stop exercising immediately and seek medical attention in time.
  • Fall: It is recommended to ensure the safety of the sports ground before exercise: keep the ground dry, clean, not easy to slip, no debris; Comfortable clothing and non-slip exercise are recommended.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The experimental group
The experimental group performed aerobic resistance exercise during pregnancy every day.
Behavioral: aerobic and resistance exercise
The experimental group performed aerobic resistance exercise during pregnancy every day.
No Intervention: The control group
The control group was given traditional nursing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood glucose
Time Frame: Collect blood samples and monitor fasting blood glucose in pregnant womendaily until delivery, it can be monitored for up to 10 months.
Fasting blood glucose in pregnant women with GDM
Collect blood samples and monitor fasting blood glucose in pregnant womendaily until delivery, it can be monitored for up to 10 months.
2 hours blood glucose
Time Frame: Collect blood samples and monitor 2 hours postprandial blood glucosedaily until delivery, it can be monitored for up to 10 months.
2 hours postprandial blood glucose in pregnant women with GDM
Collect blood samples and monitor 2 hours postprandial blood glucosedaily until delivery, it can be monitored for up to 10 months.
HbA1c
Time Frame: Collect blood samples and monitor monthly until delivery, it can be monitored for up to 10 months.
HbA1c in pregnant women with GDM
Collect blood samples and monitor monthly until delivery, it can be monitored for up to 10 months.
Maternal weight gain
Time Frame: Monitor weight daily until delivery by weighing scale, it can be monitored for up to 10 months.
Maternal Weight Gain during Pregnancy
Monitor weight daily until delivery by weighing scale, it can be monitored for up to 10 months.
Pulse
Time Frame: Monitor the pulse of pregnant women in the experimental group during exercise until delivery, it can be monitored for up to 10 months.
The pulse of pregnant women in the experimental group during exercise
Monitor the pulse of pregnant women in the experimental group during exercise until delivery, it can be monitored for up to 10 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Second Affiliated Hospital of Wenzhou Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Estimated)

May 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

April 24, 2023

First Submitted That Met QC Criteria

June 4, 2023

First Posted (Actual)

June 13, 2023

Study Record Updates

Last Update Posted (Actual)

February 6, 2024

Last Update Submitted That Met QC Criteria

February 4, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • SAHoWMU-CR2023-07-102

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aerobic and Resistance Exercise

Clinical Trials on aerobic and resistance exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe